Th17 cells in type 1 diabetes

Cellular Immunology

Volumn 280, Issue 1, 2012, Pages 16-21

  Shao, Shiying ^a   He, Fan ^a   Yang, Yan ^a   Yuan, Gang ^a   Zhang, Muxun ^a   Yu, Xuefeng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Autoimmunity; Effector T cell; Regulatory T cell; T helper 17 cell; Type 1 diabetes

Indexed keywords

CORDYCEPS SINENSIS EXTRACT; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 21; INTERLEUKIN 25; INTERLEUKIN 6; RETINOIC ACID; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN PRESENTING CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL EXPANSION; CELL FUNCTION; CYTOKINE RELEASE; DISEASE COURSE; HUMAN; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; MONOCYTE; NONHUMAN; OPHIOCORDYCEPS; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE ACTIVATION; TH17 CELL;

ANIMALS; ANTIGEN PRESENTATION; AUTOANTIGENS; CELL DIVISION; CYTOTOXICITY, IMMUNOLOGIC; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; HUMANS; INTERLEUKIN-17; INTERLEUKIN-1BETA; INTERLEUKIN-23; INTERLEUKIN-6; ISLETS OF LANGERHANS; LYMPHOPOIESIS; MICE; MICE, INBRED NOD; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; VACCINATION;

ERAGROSTIS TEF;

EID: 84871018881     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2012.11.001     Document Type: Review

References (49)

1. van Belle T.L., Coppieters K.T., von Herrath M.G. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol. Rev. 2011, 91:79-118.
2. Lehuen A., Diana J., Zaccone P., et al. Immune cell crosstalk in type 1 diabetes. Nat. Rev. Immunol. 2010, 10:501-513.
3. Bach J.F. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr. Rev. 1994, 15:516-542.
4. McKenzie B.S., Kastelein R.A., Cua D.J. Understanding the IL-23-IL-17 immune pathway. Trends Immunol. 2006, 27:17-23.
5. Morran M.P., Omenn G.S., Pietropaolo M., Sinai Mt. Immunology and genetics of type 1 diabetes. J. Med. 2008, 75:314-327.
6. Yadav D., Judkowski V., Flodstrom-Tullberg M., et al. B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets. J. Immunol. 2004, 173:3631-3639.
7. Hedegaard C.J., Krakauer M., Bendtzen K., et al. T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis. Immunology 2008, 125:161-169.
8. Katz J.D., Benoist C., Mathis D. T helper cell subsets in insulin-dependent diabetes. Science 1995, 268:1185-1188.
9. Wang B., Andre I., Gonzalez A., et al. Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes. Proc. Nat. Acad. Sci. USA 1997, 94:13844-13849.
10. Suarez-Pinzon W.L., Rabinovitch A. Approaches to type 1 diabetes prevention by intervention in cytokine immunoregulatory circuits. Int. J. Exp. Diabetes Res. 2001, 2:3-17.
11. Wang Z., Xiao L., Shi B.Y., et al. Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation. Transplant. Immunol. 2008, 19:69-73.
12. + regulatory T cells. Immunology 2007, 121:15-28.
13. + T reg cells impinge on autoimmune diabetes. J. Exp. Med. 2005, 202:1387-1397.
14. Di Lorenzo T.P., Peakman M., Roep B.O. Translational mini-review series on type 1 diabetes: systematic analysis of T cell epitopes in autoimmune diabetes. Clin. Exp. Immunol. 2007, 148:1-16.
15. Kay T.W., Parker J.L., Stephens L.A., et al. RIP-beta 2-microglobulin transgene expression restores insulitis, but not diabetes, in beta 2-microglobulin null nonobese diabetic mice. J. Immunol. 1996, 157:3688-3693.
16. Mosmann T.R., Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989, 7:145-173.
17. Fontenot J.D., Rudensky A.Y. A well adapted regulatory contrivance. Regulatory T cell development and the forkhead family transcription factor Foxp3. Nat. Immunol. 2005, 6:331-337.
18. Bettelli E., Korn T., Kuchroo V.K. Th17: the third member of the effector T cell trilogy. Curr. Opin. Immunol. 2007, 19:652-657.
19. Aggarwal S., Gurney A.L. IL-17: prototype member of an emerging cytokine family. J. Leukocyte Biol. 2002, 71:1-8.
20. Dong C. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat. Rev. Immunol. 2008, 8:337-348.
21. Veldhoen M., Hocking R.J., Atkins C.J., et al. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006, 24:179-189.
22. Korn T., Bettelli E., Gao W., et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007, 448:484-487.
23. Zhou L., Ivanov, Spolski R., et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 2007, 8:967-974.
24. + T helper cells. Cell 2006, 126:1121-1133.
25. Bettelli E., Carrier Y., Gao W., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
26. Aggarwal S., Ghilardi N., Xie M.H., et al. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 2003, 278:1910-1914.
27. Setoguchi R., Hori S., Takahashi T., et al. Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 2005, 201:723-735.
28. Nurieva R., Yang X.O., Martinez G., et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 2007, 448:480-483.
29. Korn T., Bettelli E., Oukka M., et al. IL-17 and Th17 Cells. Annu. Rev. Immunol. 2009, 27:485-517.
30. Yang X.O., Nurieva R., Martinez G.J., et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008, 29:44-56.
31. Park H., Li Z., Yang X.O., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005, 6:1133-1141.
32. Langrish C.L., Chen Y., Blumenschein W.M., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005, 201:233-240.
33. Vukkadapu S.S., Belli J.M., Ishii K., et al. Dynamic interaction between T cell-mediated beta-cell damage and beta-cell repair in the run up to autoimmune diabetes of the NOD mouse. Physiol. Genomics 2005, 21:201-211.
34. Mensah-Brown E.P., Shahin A., Al-Shamisi M., et al. IL-23 leads to diabetes induction after subdiabetogenic treatment with multiple low doses of streptozotocin. Eur. J. Immunol. 2006, 36:216-223.
35. Martin-Orozco N., Chung Y., Chang S.H., et al. Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. Eur. J. Immunol. 2009, 39:216-224.
36. Emamaullee J.A., Davis J., Merani S., et al. Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes 2009, 58:1302-1311.
37. Honkanen J., Nieminen J.K., Gao R., et al. IL-17 immunity in human type 1 diabetes. J. Immunol. 2010, 185:1959-1967.
38. Ferraro A., Socci C., Stabilini A., et al. Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes. Diabetes 2011, 60:2903-2913.
39. + regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 2009, 326:986-991.
40. Battaglia M., Roncarolo M.G. The fate of human Treg cells. Immunity 2009, 30:763-765.
41. Dahlen E., Hedlund G., Dawe K. Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation. J. Immunol. 2000, 164:2444-2456.
42. Liu S.M., Lee D.H., Sullivan J.M., et al. Differential IL-21 signaling in APCs leads to disparate Th17 differentiation in diabetes-susceptible NOD and diabetes-resistant NOD.Idd3 mice. J. Clin. Invest. 2011, 121:4303-4310.
43. Rosenblum E.B., Stajich J.E., Maddox N., et al. Global gene expression profiles for life stages of the deadly amphibian pathogen Batrachochytrium dendrobatidis. Proc. Nat. Acad. Sci. USA 2008, 105:17034-17039.
44. Evans H.G., Suddason T., Jackson I., et al. Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes. Proc. Nat. Acad. Sci. USA 2007, 104:17034-17039.
45. van den Brandt J., Fischer H.J., Walter L., et al. Type 1 diabetes in BioBreeding rats is critically linked to an imbalance between Th17 and regulatory T cells and an altered TCR repertoire. J. Immunol. 2010, 185:2285-2294.
46. Shi B., Wang Z., Jin H., et al. Immunoregulatory Cordyceps sinensis increases regulatory T cells to Th17 cell ratio and delays diabetes in NOD mice. Int. Immunopharmacol. 2009, 9:582-586.
47. + CTL in the pathogenesis of type 1 diabetes and experimental autoimmune encephalomyelitis. J. Clin. Immunol. 2011, 31:811-826.
48. Angkasekwinai P., Park H., Wang Y.H., et al. Interleukin 25 promotes the initiation of proallergic type 2 responses. J. Exp. Med. 2007, 204:1509-1517.
49. Wang M., Yang L., Sheng X., et al. T-cell vaccination leads to suppression of intrapancreatic Th17 cells through Stat3-mediated RORgammat inhibition in autoimmune diabetes. Cell. Res. 2011, 21:1358-1369.